AXSM Axsome Yalpi foyda normasi

Axsome Corp (AXSM) kompaniyasining rasmiy ramzlari

Axsome Therapeutics (AXSM) R&D markazi narkolepsiya va depressiyani davolash bo'yicha o'z pipeline'ini kengaytirgan holda, ilg'or nevrologik yechimlarni faol joriy etmoqda. Barqaror pul oqimi patentlar va bemorlarning Markaziy Nerv Tizimi (CNS) terapiyalariga rioya qilishi orqali ta'minlanmoqda. Valo martaba (gross margin) ushbu samaradorlikni aniq ko'rsatadi, bunda 92.00 joriy metrika darajasi vazifasini o'taydi. Shifokorlarning yangi dori vositalariga bo'lgan yuqori ishonchi kompaniyaning bozor imijini tezlik bilan mustahkamlamoqda.

Axsome Corp (AXSM) Yalpi rentabellik: 04.07.2022 - 19.11.2026 davri uchun

Axsome Corp (AXSM) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- emitentning moliyaviy marjinalligi ko'rsatkichlari:
Kompaniyaning jamlanma tahlili:Axsome Therapeutics, Inc. - AXSM
Axsome Therapeutics Inc brend mahsuloti

Bozor Axsome Therapeutics (AXSM) kompaniyasini molekulalarni noyob markaziy nerv tizimi (CNS) dori vositalariga aylantirish qobiliyati tufayli istiqbolli aktiv deb hisoblaydi. Tarixiy yalpi foyda marjalarining tahlili bevosita ishlab chiqarish xarajatlari chegirib tashlangangandan keyingi daromadni o'lchash imkonini beradi, bu esa antidepressantlarga bo'lgan noelast talabni hisobga olgan holda, biznesning kuchli narx belgilash imkoniyati va fundamental barqarorligini tasdiqlaydi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda bo'yicha rentabellik Biogen Corp|Yalpi foyda bo'yicha rentabellik NBIX|Regencell Corp (RGC) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik acadia-pharm.com (ACAD)|Yalpi marja Xenon Pharmaceuticals (XENE)|Yalpi rentabellik Viking Therapeutics VKTX|Yalpi foyda normasi SUPN|CPRX - Yalpi rentabellik|Yalpi foyda marjasi Denali Therapeutics|HRMY: Yalpi marja|Biohaven - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik AMLX|Trevi Therapeutics, Inc. (TRVI) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi foyda bo'yicha rentabellik PRAX (Praxis Medicines)|Anavex Corp - Sotuvning yalpi rentabelligi|Yalpi rentabellik CeriBell CBLL|Yalpi foyda bo'yicha sotuv rentabelligi Prothena Biosciences (PRTA)|ALEC: Yalpi foyda bo'yicha rentabellik|ANNX - Yalpi marja|Omeros Corp. (OMER) - Yalpi rentabellik|Yalpi foyda marjasi Neurogene Inc. (NGNE)|Yalpi foyda bo'yicha rentabellik ACIU|Yalpi rentabellik VYGR|Yalpi rentabellik Neumora (NMRA)|SCLX - Yalpi foyda marjasi|Yalpi marja TVGN (Tevogen Bio Holdings Inc.)|Yalpi foyda normasi ACOG|Cognition Therapeutics Inc. - Yalpi marja|IKT - Yalpi marja|SAVA: Yalpi marja|Assertio Holdings, Inc. - Yalpi foyda normasi|COYA (Coya) - Yalpi marja|Sotuvning yalpi rentabelligi VTGN (Vistagen Therapeutics)|Yalpi rentabellik Ovid Rx (OVID)|Acumen Pharmaceuticals - Sotuvning yalpi rentabelligi|Yalpi rentabellik CervoMed, Inc. CRVO|Yalpi marja Alterity Therapeutics ATHE|CLNN: Yalpi foyda bo'yicha rentabellik|PEPG (pepgen.com) - Sotuvning yalpi rentabelligi|Jupiter Neurosciences Inc (JUNS) - Yalpi rentabellik|Relmada Therapeutics - Yalpi foyda normasi|ANVS (Annovis Bio Inc) - Yalpi marja|GRCE: Yalpi foyda normasi|Yalpi rentabellik Firefly Neuroscience Inc (AIFF)|KLTO (ANEW Medical) - Yalpi foyda normasi|Yalpi rentabellik neurosense-tx.com NRSN|Reviva Pharmaceuticals Holdings, Inc. (RVPH) - Yalpi foyda marjasi|MTVA: Yalpi foyda bo'yicha rentabellik|NeurAxis, Inc (NRXS) - Yalpi foyda bo'yicha rentabellik|HSDT: Yalpi marja|PASG - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Neuphoria Therapeutics, Inc.|Yalpi rentabellik NERV|Yalpi marja ATHA|ADXN (Addex Therapeutics Ltd) - Yalpi foyda normasi|Yalpi rentabellik alzamend.com ALZN|Yalpi foyda bo'yicha sotuv rentabelligi Cyclerion Therapeutics (CYCN)|Protagenic - Yalpi marja|Yalpi foyda normasi KTTA (Pasithea Therapeutics Corp)|CRGT: Yalpi marja|Avenue Therapeutics Inc. (ATXI) - Yalpi marja|BCLI (BrainStorm Cell Therapeutics Inc.) - Yalpi marja|Yalpi marja Cara Therapeutics Inc|Yalpi rentabellik Chromocell Therapeutics (CHRO)|Yalpi foyda koeffitsiyenti ELYM|Yalpi rentabellik Intra-Cellular ITCI|LBPH: Sotuvning yalpi rentabelligi|MRNS - Yalpi rentabellik|NKGen Biotech, Inc. (NKGN) - Yalpi foyda bo'yicha rentabellik|neurobopharma.com (NRBO) - Yalpi rentabellik|SAGE: Yalpi foyda koeffitsiyenti|Yalpi rentabellik Synaptogenix, Inc.|Yalpi rentabellik TRVN|Yalpi marja VIGL|Yalpi marja anewmeds.com (WENA)|Yalpi marja CERE (cerevel.com)